Oncology News: CAR T Cells Tied to Longer Remission, More Care Days in FL (+...)

Oncology News CAR T Cells Tied to Longer Remission, More Care Days in FL Researchers compare survival and time spent in healthcare with CAR T cells vs bispecific antibodies in patients with relapsed or refractory follicular lymphoma treated in the third line or later. Medscape Medical News, November 13, 2026 https://www.medscape.com/index/list_13474_0